How Global Trends Are Driving Patient-Centricity in Parenteral Products.
08/11/2021
After only one year our location in Austria has been modified to the high Vetter quality standards as it prepares to begin manufacturing.
07/21/2021
The key to successful development and guiding a drug to approval is early planning.
06/29/2021
Fast, safe and efficient: the new Vetter ID determination of oligonucleotides.
06/21/2021
92 percent of our colleagues in Chicago named Vetter a “Great Place to Work” company!
06/14/2021
In this article Senior Vice President Kai Vogt talks about the opportunities of digital transformation at Vetter.
06/09/2021
Renewed award confirms continuity and the approach to sustainability.
05/25/2021
Rentschler Biopharma and Vetter announced today that their strategic collaboration has taken key steps forward.
04/21/2021
Interview with Oskar Gold, SVP Asia Pacific and Global Emerging Markets
04/19/2021
Vetter expands its activities in Asia. The new office, located in the heart of Shanghai's Central Business District.
03/05/2021
Winning five core categories reaffirms Vetter as a trusted solution provider.
02/18/2021
Around four million people in Germany live with one of the approximately 6,000 various rare diseases.
02/17/2021
![[Translate to Englisch:]](/media/_processed_/f/f/csm_Vetter_gewinnt_erneut_Axia_Best_Managed_Companies_Award_abe3bcb852.jpg "[Translate to Englisch:]")
![[Translate to Englisch:]](/media/_processed_/6/1/csm_Vetter-baut-seine-Aktivitaten-in-China-weiter-aus_11cc9e2a65.jpg "[Translate to Englisch:]")
![[Translate to Englisch:]](/media/content/bilder/awards/CMO_Leadership_award.jpg "[Translate to Englisch:]")
